Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
about
From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel BiomarkersPeripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapyS100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transitionClinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix.Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodelingExpression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinomaPost-operative recurrent trachomatous trichiasis is associated with increased conjunctival expression of S100A7 (psoriasin).TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion.Laser ionization mass spectrometry in oral squamous cell carcinoma.New insight into benign tumours of major salivary glands by proteomic approach.Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.The Characteristics and Function of S100A7 Induction in Squamous Cell Carcinoma: Heterogeneity, Promotion of Cell Proliferation and Suppression of DifferentiationAnticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy.Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancerThe Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.Functions of S100 proteins.S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells.S100 protein family in human cancer.Proteomic Characterization Reveals a Molecular Portrait of Nasopharyngeal Carcinoma Differentiation.Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: A immunohistochemical study.S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma.S100A7: from mechanism to cancer therapy.Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer.Human β-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches.Differentially expressed proteins in positive versus negative HNSCC lymph nodes
P2860
Q28078702-5F6F3A0B-73DD-46C4-9CA8-54762D9131B7Q28394867-283ABB35-A958-41E3-92BD-4F5978056FE3Q33648661-B04401F9-F23F-4DAB-8217-FEDDB14711F1Q33648719-B01DC5FC-2FDA-473D-A7B5-73846A5E371EQ33721304-A46BD1BE-FF5E-4056-82A7-8D63F73CE473Q33804642-EE78BD30-7576-4586-A574-D26031DFA2EBQ34074109-BBCA5B5B-6F41-41A4-AC40-21D68DD02B14Q34535324-E65A9012-07DC-420F-97B0-277A1F141ACDQ34713738-CC63D30D-7016-4E40-BF7A-93B94117A4FEQ35013394-552CA5C2-3FAE-444B-A3DB-120E70A391A4Q35037000-A04E2322-1B14-4A30-A480-957433382C35Q35079487-A24BECF9-C7AA-4102-8BA2-95BA2B09A470Q35656741-49396305-DFE2-4438-91DD-AADAEF16D26FQ35675984-F39634EA-018D-41EC-B3DC-A9EDFD6D5C34Q35818215-232801CB-B1C4-4D46-80F4-90BFC1D9B0A6Q36209802-9359E6B9-8832-4885-B035-908C85663D9BQ37001259-05984B5F-26D3-4923-A612-0019D0FBF1C8Q37437428-6E1C4A01-447B-44E9-816B-D177AB4488E2Q37650123-503CCE11-24D5-4BAA-A5B0-642015AD898BQ37726397-F9EA4F05-3EC8-40F8-A3ED-CED096962BCAQ41811874-C2905F2B-6D56-4295-813B-8B91E392495CQ41908075-1010371D-D7B1-43D3-88EC-DA5B60E225C6Q43972741-3116938C-51E7-43EC-A963-291C168CA2DBQ47548821-85E32B74-8B7D-4DEE-8184-B3E1AF543BA1Q47927472-54F207C5-E2DC-4C1A-A494-F2C3226A22C8Q52614372-77B9E52C-9D3B-4DD8-B6B5-D7BFC5F50AD8Q54335180-19523EBC-2603-49A4-A54E-A6354C456462Q58696306-A6E59037-D007-4677-989C-AB772EB682DA
P2860
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
@ast
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
@en
type
label
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
@ast
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
@en
prefLabel
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
@ast
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
@en
P2093
P2860
P1433
P1476
Nuclear S100A7 is associated with poor prognosis in head and neck cancer
@en
P2093
Ajay Matta
Alok Thakar
Jorg Grigull
K W Michael Siu
Nootan Kumar Shukla
Ranju Ralhan
Ritu Duggal
Shyam Singh Chauhan
Siddhartha DattaGupta
P2860
P304
P356
10.1371/JOURNAL.PONE.0011939
P407
P577
2010-08-03T00:00:00Z